MarketCap
Facebook
X
TelegramFluidigm Corporation ROE 2011-2026 | FLDM
ROE Jährlich Fluidigm Corporation
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| -38.13 | -42.18 | -81.83 | -195.68 | -142.74 | -46.4 | -35.12 | -17.14 | -18.9 | -39.49 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -17.14 | -195.68 | -65.76 |
ROE anderer Aktien in der Diagnostik & Forschung
| Name | ROE | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Agilent Technologies
A
|
22.45 | $ 121.02 | 1.7 % | $ 36.8 B |  USA |
 |
Anixa Biosciences
ANIX
|
-72.07 | $ 2.96 | 4.71 % | $ 96.1 K | USA |
 |
Centogene N.V.
CNTG
|
-170.35 | - | -6.23 % | $ 30.6 M |  Germany |
|
Akumin
AKU
|
325.23 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Aspira Women's Health
AWH
|
-403.65 | - | -6.19 % | $ 10.5 M | USA |
 |
Burning Rock Biotech Limited
BNR
|
-43.17 | $ 22.3 | -5.27 % | $ 234 M |  China |
 |
Celcuity
CELC
|
-96.68 | $ 111.31 | 3.64 % | $ 4.39 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-0.85 | - | - | $ 562 M |  Britain |
 |
Co-Diagnostics
CODX
|
-41.08 | - | - | $ 79.8 M | USA |
 |
Charles River Laboratories International
CRL
|
-4.56 | $ 180.97 | 2.92 % | $ 8.97 B | USA |
 |
Castle Biosciences
CSTL
|
4.0 | $ 28.14 | 2.07 % | $ 782 M | USA |
 |
Accelerate Diagnostics
AXDX
|
65.62 | - | -61.36 % | $ 2.46 M | USA |
 |
DermTech
DMTK
|
-176.45 | - | -11.32 % | $ 2.94 M | USA |
 |
Global Cord Blood Corporation
CO
|
10.27 | - | - | $ 399 M | China |
 |
Genetic Technologies Limited
GENE
|
-43.4 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-181.33 | - | 0.12 % | $ 80.1 M | China |
 |
Fulgent Genetics
FLGT
|
-3.77 | $ 14.14 | 2.56 % | $ 428 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
13.32 | - | - | $ 10.7 B | USA |
|
Biodesix
BDSX
|
-205.65 | $ 14.71 | -5.1 % | $ 1.91 B | USA |
 |
Biocept
BIOC
|
-362.16 | - | -13.05 % | $ 7.29 M | USA |
 |
Heska Corporation
HSKA
|
-4.71 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-400.51 | - | -20.0 % | $ 1.06 M | USA |
 |
BioNano Genomics
BNGO
|
-316.66 | $ 1.14 | 1.88 % | $ 1.45 M | USA |
 |
IDEXX Laboratories
IDXX
|
65.99 | $ 650.0 | 2.28 % | $ 52.3 B | USA |
 |
Illumina
ILMN
|
-51.54 | $ 129.59 | 0.02 % | $ 20.6 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
13.84 | $ 208.63 | 0.13 % | $ 23.2 B | USA |
 |
Danaher Corporation
DHR
|
6.88 | $ 205.32 | 0.63 % | $ 146 B | USA |
 |
Organovo Holdings
ONVO
|
-23.71 | - | -2.3 % | $ 19.4 M | USA |
 |
Exact Sciences Corporation
EXAS
|
-8.66 | $ 103.51 | 0.13 % | $ 19.5 B | USA |
 |
Bioventus
BVS
|
-90.0 | $ 8.42 | -3.66 % | $ 527 M | USA |
 |
DarioHealth Corp.
DRIO
|
-102.21 | $ 9.65 | -6.26 % | $ 274 M |  Israel |
 |
DexCom
DXCM
|
30.46 | $ 73.39 | 0.42 % | $ 28.6 B | USA |
 |
Laboratory Corporation of America Holdings
LH
|
10.17 | $ 281.11 | -0.69 % | $ 23.4 B | USA |
 |
QIAGEN N.V.
QGEN
|
2.34 | - | - | $ 10.6 B |  Niderland |
 |
Lantheus Holdings
LNTH
|
21.43 | $ 77.74 | -1.4 % | $ 5.25 B | USA |
 |
ICON Public Limited Company
ICLR
|
8.31 | $ 110.81 | 1.94 % | $ 9.14 B |  Irlanda |
 |
CareDx, Inc
CDNA
|
-7.05 | $ 19.28 | 2.56 % | $ 1.03 B | USA |
 |
Chembio Diagnostics
CEMI
|
-130.86 | - | 0.22 % | $ 16.8 M | USA |
 |
Motus GI Holdings
MOTS
|
-478.86 | - | -34.28 % | $ 263 K | Israel |
 |
Check-Cap Ltd.
CHEK
|
1734.41 | - | - | $ 9.42 M | Israel |
 |
Mettler-Toledo International
MTD
|
-3677.41 | $ 1 290.77 | -1.92 % | $ 26.6 B |  Schweiz |
 |
Guardant Health
GH
|
419.18 | $ 93.95 | 0.7 % | $ 11.8 B | USA |
 |
Myriad Genetics
MYGN
|
-99.43 | $ 5.35 | 1.04 % | $ 495 M | USA |
 |
IQVIA Holdings
IQV
|
20.91 | $ 177.49 | 2.0 % | $ 30.5 B | USA |
 |
Brainsway Ltd.
BWAY
|
-27.43 | $ 12.53 | 8.11 % | $ 99.4 M | Israel |
 |
NeoGenomics
NEO
|
-12.91 | $ 9.14 | -4.25 % | $ 1.17 B | USA |
 |
National Research Corporation
NRC
|
63.26 | $ 13.25 | -1.05 % | $ 325 M | USA |
 |
Enzo Biochem
ENZ
|
-46.47 | - | -8.98 % | $ 14.8 K | USA |
 |
Natera
NTRA
|
-77.62 | $ 204.02 | -1.46 % | $ 20.1 B | USA |